| Source HCPCS Code |
|
Target NDC Code |
Q5123
Inj, rituximab-arrx, biosimilar, (riabni), 10 mg
|
⇄
|
55513-0224-01
RIABNI 100 MG/10 ML VIAL
|
| Detail Information |
| Relationship Start Date |
07/01/2021 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
Q5123
Inj, rituximab-arrx, biosimilar, (riabni), 10 mg
|
⇄
|
55513-0326-01
RIABNI 500 MG/50 ML VIAL
|
| Detail Information |
| Relationship Start Date |
07/01/2021 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
Q5123
Inj. riabni, 10 mg
|
⇄
|
55513-0224-01
Riabni
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q5123
Inj. riabni, 10 mg
|
⇄
|
55513-0326-01
Riabni
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|